JP2011529492A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2011529492A5 JP2011529492A5 JP2011521085A JP2011521085A JP2011529492A5 JP 2011529492 A5 JP2011529492 A5 JP 2011529492A5 JP 2011521085 A JP2011521085 A JP 2011521085A JP 2011521085 A JP2011521085 A JP 2011521085A JP 2011529492 A5 JP2011529492 A5 JP 2011529492A5
- Authority
- JP
- Japan
- Prior art keywords
- fibrosis
- cancer
- therapeutic agent
- pancreatic
- liver
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 206010016654 Fibrosis Diseases 0.000 claims 5
- 230000004761 fibrosis Effects 0.000 claims 4
- 208000019425 cirrhosis of liver Diseases 0.000 claims 2
- 210000001260 vocal cord Anatomy 0.000 claims 2
- 206010006187 Breast cancer Diseases 0.000 claims 1
- 208000026310 Breast neoplasm Diseases 0.000 claims 1
- 206010009944 Colon cancer Diseases 0.000 claims 1
- 201000003883 Cystic fibrosis Diseases 0.000 claims 1
- 201000009794 Idiopathic Pulmonary Fibrosis Diseases 0.000 claims 1
- 206010058467 Lung neoplasm malignant Diseases 0.000 claims 1
- 206010061902 Pancreatic neoplasm Diseases 0.000 claims 1
- 206010033645 Pancreatitis Diseases 0.000 claims 1
- 206010034665 Peritoneal fibrosis Diseases 0.000 claims 1
- 208000005718 Stomach Neoplasms Diseases 0.000 claims 1
- 230000007882 cirrhosis Effects 0.000 claims 1
- 208000029742 colonic neoplasm Diseases 0.000 claims 1
- 206010017758 gastric cancer Diseases 0.000 claims 1
- 208000036971 interstitial lung disease 2 Diseases 0.000 claims 1
- 201000007270 liver cancer Diseases 0.000 claims 1
- 208000014018 liver neoplasm Diseases 0.000 claims 1
- 201000005202 lung cancer Diseases 0.000 claims 1
- 208000020816 lung neoplasm Diseases 0.000 claims 1
- 208000015486 malignant pancreatic neoplasm Diseases 0.000 claims 1
- 206010028537 myelofibrosis Diseases 0.000 claims 1
- 201000002528 pancreatic cancer Diseases 0.000 claims 1
- 208000008443 pancreatic carcinoma Diseases 0.000 claims 1
- 239000008194 pharmaceutical composition Substances 0.000 claims 1
- 208000003476 primary myelofibrosis Diseases 0.000 claims 1
- 208000005069 pulmonary fibrosis Diseases 0.000 claims 1
- 230000037390 scarring Effects 0.000 claims 1
- 201000011549 stomach cancer Diseases 0.000 claims 1
- 230000009885 systemic effect Effects 0.000 claims 1
- 239000003814 drug Substances 0.000 description 11
- 229940124597 therapeutic agent Drugs 0.000 description 11
- 108020004459 Small interfering RNA Proteins 0.000 description 5
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 4
- 108020004707 nucleic acids Proteins 0.000 description 3
- 102000039446 nucleic acids Human genes 0.000 description 3
- 150000007523 nucleic acids Chemical class 0.000 description 3
- 102000008186 Collagen Human genes 0.000 description 2
- 108010035532 Collagen Proteins 0.000 description 2
- 102000001214 HSP47 Heat-Shock Proteins Human genes 0.000 description 2
- 108010055039 HSP47 Heat-Shock Proteins Proteins 0.000 description 2
- 108010006519 Molecular Chaperones Proteins 0.000 description 2
- 102000005431 Molecular Chaperones Human genes 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 229920001436 collagen Polymers 0.000 description 2
- 230000008878 coupling Effects 0.000 description 2
- 238000010168 coupling process Methods 0.000 description 2
- 238000005859 coupling reaction Methods 0.000 description 2
- 230000008685 targeting Effects 0.000 description 2
- 108020004414 DNA Proteins 0.000 description 1
- 101000998548 Yersinia ruckeri Alkaline proteinase inhibitor Proteins 0.000 description 1
- 230000000692 anti-sense effect Effects 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 239000003475 metalloproteinase inhibitor Substances 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
Applications Claiming Priority (13)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US8494708P | 2008-07-30 | 2008-07-30 | |
| US8497708P | 2008-07-30 | 2008-07-30 | |
| US8496808P | 2008-07-30 | 2008-07-30 | |
| US8493908P | 2008-07-30 | 2008-07-30 | |
| US8495508P | 2008-07-30 | 2008-07-30 | |
| US8496408P | 2008-07-30 | 2008-07-30 | |
| US61/084,955 | 2008-07-30 | ||
| US61/084,964 | 2008-07-30 | ||
| US61/084,968 | 2008-07-30 | ||
| US61/084,947 | 2008-07-30 | ||
| US61/084,939 | 2008-07-30 | ||
| US61/084,977 | 2008-07-30 | ||
| PCT/US2008/076295 WO2010014117A1 (en) | 2008-07-30 | 2008-09-12 | Drug carriers |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014019952A Division JP2014129364A (ja) | 2008-07-30 | 2014-02-05 | 薬物担体 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2011529492A JP2011529492A (ja) | 2011-12-08 |
| JP2011529492A5 true JP2011529492A5 (enExample) | 2012-03-22 |
Family
ID=40627040
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2011521085A Pending JP2011529492A (ja) | 2008-07-30 | 2008-09-12 | 薬物担体 |
| JP2014019952A Pending JP2014129364A (ja) | 2008-07-30 | 2014-02-05 | 薬物担体 |
| JP2015228674A Pending JP2016104732A (ja) | 2008-07-30 | 2015-11-24 | 薬物担体 |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014019952A Pending JP2014129364A (ja) | 2008-07-30 | 2014-02-05 | 薬物担体 |
| JP2015228674A Pending JP2016104732A (ja) | 2008-07-30 | 2015-11-24 | 薬物担体 |
Country Status (11)
| Country | Link |
|---|---|
| US (2) | US20100028416A1 (enExample) |
| EP (1) | EP2323693B1 (enExample) |
| JP (3) | JP2011529492A (enExample) |
| KR (2) | KR20140065017A (enExample) |
| CN (1) | CN102159247A (enExample) |
| AU (1) | AU2008359989A1 (enExample) |
| CA (1) | CA2732412C (enExample) |
| ES (1) | ES2657214T3 (enExample) |
| RU (2) | RU2505315C2 (enExample) |
| TW (1) | TW201004646A (enExample) |
| WO (1) | WO2010014117A1 (enExample) |
Families Citing this family (55)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7358223B2 (en) | 2004-10-04 | 2008-04-15 | Nitto Denko Corporation | Biodegradable cationic polymers |
| PT2730277T (pt) | 2004-12-22 | 2020-04-21 | Nitto Denko Corp | Veículo de fármaco e kit de veículo de fármaco para a inibição da fibrose |
| US20120269886A1 (en) | 2004-12-22 | 2012-10-25 | Nitto Denko Corporation | Therapeutic agent for pulmonary fibrosis |
| US9393315B2 (en) | 2011-06-08 | 2016-07-19 | Nitto Denko Corporation | Compounds for targeting drug delivery and enhancing siRNA activity |
| JP2009221164A (ja) * | 2008-03-17 | 2009-10-01 | Nitto Denko Corp | 肺線維症処置剤 |
| US9572886B2 (en) * | 2005-12-22 | 2017-02-21 | Nitto Denko Corporation | Agent for treating myelofibrosis |
| JP5342834B2 (ja) * | 2008-09-05 | 2013-11-13 | 日東電工株式会社 | 骨髄線維症処置剤 |
| TWI407971B (zh) | 2007-03-30 | 2013-09-11 | Nitto Denko Corp | Cancer cells and tumor-related fibroblasts |
| US20080312174A1 (en) * | 2007-06-05 | 2008-12-18 | Nitto Denko Corporation | Water soluble crosslinked polymers |
| CA2698812A1 (en) | 2007-09-14 | 2009-03-19 | Nitto Denko Corporation | Drug carriers |
| WO2010029760A1 (en) * | 2008-09-12 | 2010-03-18 | Nitto Denko Corporation | Imaging agents of fibrotic diseases |
| ES2562499T3 (es) * | 2009-12-09 | 2016-03-04 | Nitto Denko Corporation | Modulación de la expresión de HSP47 |
| RU2711531C2 (ru) * | 2010-06-17 | 2020-01-17 | Нитто Денко Корпорейшн | Средство для лечения фиброза почек |
| JP5950428B2 (ja) | 2010-08-05 | 2016-07-13 | 日東電工株式会社 | 線維化組織から正常組織を再生するための組成物 |
| CN102652835A (zh) * | 2010-12-10 | 2012-09-05 | 邹长坪 | 缓释高分子维甲酸 |
| US9011903B2 (en) | 2011-06-08 | 2015-04-21 | Nitto Denko Corporation | Cationic lipids for therapeutic agent delivery formulations |
| KR102038300B1 (ko) * | 2011-06-08 | 2019-10-31 | 닛토덴코 가부시키가이샤 | 표적 약물 전달체 및 ｓｉＲＮＡ 활성을 증가시키는 화합물 |
| TWI658830B (zh) | 2011-06-08 | 2019-05-11 | 日東電工股份有限公司 | Ｈｓｐ47表現調控強化用類視色素脂質體 |
| US10196637B2 (en) | 2011-06-08 | 2019-02-05 | Nitto Denko Corporation | Retinoid-lipid drug carrier |
| AU2011371755B2 (en) | 2011-06-21 | 2017-09-07 | Nitto Denko Corporation | Apoptosis-inducing agent |
| US20140323550A1 (en) * | 2011-11-18 | 2014-10-30 | Nitto Denko Corporation | Intestinal fibrosis treatment agent |
| JP6262209B2 (ja) * | 2012-05-07 | 2018-01-17 | 日東電工株式会社 | リンカーを有するポリマー結合体 |
| US10888625B2 (en) * | 2012-10-30 | 2021-01-12 | Particle Sciences, Inc. | Drug delivery particle formulations with targeting moieties |
| JP6340162B2 (ja) | 2012-12-20 | 2018-06-06 | 日東電工株式会社 | アポトーシス誘導剤 |
| JP6076076B2 (ja) | 2012-12-21 | 2017-02-08 | 日東電工株式会社 | 組織再生促進剤 |
| US9839694B2 (en) * | 2013-04-26 | 2017-12-12 | Nitto Denko Corporation | Reduction of endotoxins from polyanionic polymer conjugates |
| KR102091588B1 (ko) * | 2013-05-27 | 2020-03-24 | 주식회사 바이오리더스 | 폴리감마글루탐산을 함유하는 점액 분산 또는 수화용 조성물 |
| EP2823811A1 (en) * | 2013-07-09 | 2015-01-14 | OTC GmbH | Targeted active release system comprising solid lipid nano-particles |
| WO2015034930A1 (en) * | 2013-09-03 | 2015-03-12 | William Marsh Rice University | Treatment of inflammatory diseases by carbon materials |
| US11430024B2 (en) * | 2013-09-04 | 2022-08-30 | Amos M. Cohen | System and method of providing a virtual guestbook |
| IN2013MU03918A (enExample) * | 2013-12-13 | 2015-09-25 | Cipla Ltd | |
| US9976142B2 (en) | 2014-04-02 | 2018-05-22 | Nitto Denko Corporation | Targeting molecule and a use thereof |
| JP6480467B2 (ja) * | 2014-04-07 | 2019-03-13 | 日東電工株式会社 | 疎水性薬物送達のための新規なポリマーベースのヒドロトロープ |
| WO2015195476A1 (en) | 2014-06-16 | 2015-12-23 | Mayo Foundation For Medical Education And Research | Treating myelomas |
| CN106573062B (zh) | 2014-06-17 | 2020-08-25 | 日东电工株式会社 | 细胞凋亡诱导剂 |
| RU2575925C1 (ru) * | 2014-11-06 | 2016-02-27 | Федеральное государственное бюджетное образовательное учреждение высшего профессионального образования "Московский государственный университет тонких химических технологий имени М.В. Ломоносова" (МИТХТ им. М.В. Ломоносова) | Тетравалентные неогликоконъюгаты с углеводным разветвляющим ядром и способ их получения |
| US10264976B2 (en) * | 2014-12-26 | 2019-04-23 | The University Of Akron | Biocompatible flavonoid compounds for organelle and cell imaging |
| TW201707725A (zh) | 2015-08-18 | 2017-03-01 | 美國馬友醫藥教育研究基金會 | 載體－抗體組合物及其製造及使用方法 |
| ES2883290T3 (es) * | 2015-09-15 | 2021-12-07 | Samyang Holdings Corp | Composición farmacéutica para el suministro de un fármaco aniónico |
| TW201713360A (en) | 2015-10-06 | 2017-04-16 | Mayo Foundation | Methods of treating cancer using compositions of antibodies and carrier proteins |
| US11571469B2 (en) | 2016-01-07 | 2023-02-07 | Mayo Foundation For Medical Education And Research | Methods of treating cancer with interferon wherein the cancer cells are HLA negative or have reduced HLA expression |
| AU2017238119A1 (en) | 2016-03-21 | 2018-10-11 | Mayo Foundation For Medical Education And Research | Methods for reducing toxicity of a chemotherapeutic drug |
| EP3432928A4 (en) | 2016-03-21 | 2019-11-20 | Mayo Foundation for Medical Education and Research | PROCESS FOR IMPROVING THE THERAPEUTIC INDEX FOR CHEMOTHERAPEUTIC |
| US10618969B2 (en) | 2016-04-06 | 2020-04-14 | Mayo Foundation For Medical Education And Research | Carrier-binding agent compositions and methods of making and using the same |
| MX2019002474A (es) | 2016-09-01 | 2019-09-18 | Mayo Found Medical Education & Res | Composiciones de agente de unión de portador-ligando-1 de muerte programada y métodos de uso de las mismas para el tratamiento de cánceres. |
| RU2019110071A (ru) | 2016-09-06 | 2020-10-08 | Мэйо Фаундейшн Фор Медикал Эдьюкейшн Энд Рисерч | Способы лечения злокачественных новообразований, экспрессирующих pd-l1 |
| CN109890422A (zh) | 2016-09-06 | 2019-06-14 | 梅约医学教育与研究基金会 | 紫杉醇-白蛋白-结合剂组合物及使用和制备该组合物的方法 |
| WO2018048815A1 (en) | 2016-09-06 | 2018-03-15 | Nantibodyfc, Llc | Methods of treating triple-negative breast cancer using compositions of antibodies and carrier proteins |
| RU2703624C2 (ru) * | 2017-11-10 | 2019-10-21 | Федеральное государственное бюджетное образовательное учреждение высшего образования "Московский государственный университет имени М.В. Ломоносова" (МГУ) | Коаксиальные регулярные нано-мезоструктуры, способ их получения и способ получения микрокапсул из этих структур |
| US11590080B2 (en) | 2017-12-18 | 2023-02-28 | C.R. Bard, Inc. | Drug-loaded biodegradable microbead compositions including drug-containing vesicular agents |
| WO2019126169A1 (en) | 2017-12-18 | 2019-06-27 | C. R. Bard, Inc. | Drug-loaded microbead compositions, embolization compositions and associated methods |
| KR20200087594A (ko) * | 2019-01-11 | 2020-07-21 | 한국화학연구원 | 레티노익산을 포함하는 미립구형 서방출 제제 및 그의 제조방법 |
| CN114514015B (zh) | 2019-09-19 | 2025-01-07 | 丹麦科技大学 | 免疫刺激胶束组合物 |
| WO2021067914A1 (en) * | 2019-10-03 | 2021-04-08 | The Trustees Of Columbia University In The City Of New York | Combination therapy for acute myeloid leukemia, myelodysplastic syndromes and other blood diseases and disorders |
| KR20220128568A (ko) * | 2021-03-12 | 2022-09-21 | 주식회사 엑소스템텍 | 비타민 a로 표면개질된 엑소좀을 포함하는 간 섬유증 예방 또는 치료용 약학적 조성물 |
Family Cites Families (58)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CH667874A5 (fr) * | 1985-12-19 | 1988-11-15 | Battelle Memorial Institute | Polypeptide synthetique biodegradable et son utilisation pour la preparation de medicaments. |
| US5541297A (en) * | 1988-04-01 | 1996-07-30 | Immunomedics, Inc. | Therapeutic conjugates of toxins and drugs |
| FR2664500B1 (fr) * | 1990-07-13 | 1994-10-28 | Lille Ii Universite Droit Sant | Procede de preparation d'une lipoproteine modifiee par incorporation d'une substance active lipophile, lipoproteine modifiee ainsi obtenue et composition pharmaceutique ou cosmetique la contenant. |
| US6093706A (en) * | 1992-03-04 | 2000-07-25 | Bioresponse, L.L.C. | Combined dehydroepiandrosterone and retinoid therapy for epithelial disorders |
| DE4236237A1 (de) * | 1992-10-27 | 1994-04-28 | Behringwerke Ag | Prodrugs, ihre Herstellung und Verwendung als Arzneimittel |
| US5965566A (en) * | 1993-10-20 | 1999-10-12 | Enzon, Inc. | High molecular weight polymer-based prodrugs |
| US5786387A (en) * | 1994-03-23 | 1998-07-28 | Meiji Seika Kabushiki Kaisha | Lipid double-chain derivative containing polyoxyethylene |
| US6326356B1 (en) * | 1996-10-18 | 2001-12-04 | Board Of Regents, The University Of Texas System | Suppression of neu overexpression using a mini-E1A gene |
| US5824685A (en) * | 1995-02-01 | 1998-10-20 | The Johns Hopkins University School Of Medicine | Method of preventing proliferation of retinal pigment epithelium by retinoic acid receptor agonists |
| US6033849A (en) * | 1995-05-26 | 2000-03-07 | The Salk Institute For Biological Studies | Method for isolation of extrachromosomal amplified genes |
| CN1156961A (zh) * | 1995-06-09 | 1997-08-13 | 欧罗赛铁克股份有限公司 | 产生长效局部麻醉的制剂和方法 |
| US6120794A (en) * | 1995-09-26 | 2000-09-19 | University Of Pittsburgh | Emulsion and micellar formulations for the delivery of biologically active substances to cells |
| US6183774B1 (en) * | 1996-01-31 | 2001-02-06 | Collaborative Laboratories, Inc. | Stabilizing vitamin A derivatives by encapsulation in lipid vesicles formed with alkylammonium fatty acid salts |
| US6441025B2 (en) * | 1996-03-12 | 2002-08-27 | Pg-Txl Company, L.P. | Water soluble paclitaxel derivatives |
| AU735900B2 (en) * | 1996-03-12 | 2001-07-19 | Pg-Txl Company, L.P. | Water soluble paclitaxel prodrugs |
| ZA972087B (en) * | 1996-03-15 | 1997-10-24 | Theratech Inc | Targeting macromolecular produgs to T lymphocytes. |
| AU733737B2 (en) * | 1996-03-20 | 2001-05-24 | Board Of Regents, The University Of Texas System | Sensitization of her-2/neu overexpressing cancer cells to chemotherapy |
| US6566353B2 (en) * | 1996-12-30 | 2003-05-20 | Bone Care International, Inc. | Method of treating malignancy associated hypercalcemia using active vitamin D analogues |
| US6120751A (en) * | 1997-03-21 | 2000-09-19 | Imarx Pharmaceutical Corp. | Charged lipids and uses for the same |
| US6683048B1 (en) * | 1997-04-10 | 2004-01-27 | Mcgill University | Compounds and methods for stimulating gene expression and cellular differentiation |
| WO1999009045A1 (en) * | 1997-08-20 | 1999-02-25 | Somagenics, Inc. | Antisense and antigene therapeutics with improved binding properties and methods for their use |
| AU1124499A (en) * | 1997-10-28 | 1999-05-17 | Maxygen, Inc. | Human papillomavirus vectors |
| DE19756235A1 (de) * | 1997-12-17 | 1999-07-01 | Klinge Co Chem Pharm Fab | Neue piperidinylsubstituierte Pyridylalkan- alken- und -alkincarbonsäureamide |
| US6093743A (en) * | 1998-06-23 | 2000-07-25 | Medinox Inc. | Therapeutic methods employing disulfide derivatives of dithiocarbamates and compositions useful therefor |
| US6596770B2 (en) * | 2000-05-05 | 2003-07-22 | Medinox, Inc. | Therapeutic methods employing disulfide derivatives of dithiocarbamates and compositions useful therefor |
| ATE300947T1 (de) * | 1998-12-18 | 2005-08-15 | Scios Inc | Behandlung von erkrankungen mit zystenbildung |
| US6900187B2 (en) * | 1999-02-26 | 2005-05-31 | The University Of British Columbia | TRPM-2 antisense therapy using an oligonucleotide having 2′-O-(2-methoxy)ethyl modifications |
| FR2790405B1 (fr) * | 1999-03-02 | 2001-04-20 | Oreal | Nanocapsules a base de polymeres dendritiques |
| EP2308833A3 (en) * | 1999-04-15 | 2011-09-28 | Bristol-Myers Squibb Company | Cyclic protein tyrosine kinase inhibitors |
| US6319510B1 (en) * | 1999-04-20 | 2001-11-20 | Alayne Yates | Gum pad for delivery of medication to mucosal tissues |
| US6663606B1 (en) * | 1999-10-28 | 2003-12-16 | Scimed Life Systems, Inc. | Biocompatible medical devices |
| US20020041898A1 (en) * | 2000-01-05 | 2002-04-11 | Unger Evan C. | Novel targeted delivery systems for bioactive agents |
| US6566385B2 (en) * | 2000-01-12 | 2003-05-20 | Merck & Co., Inc. | Inhibitors of prenyl-protein transferase |
| WO2001057025A1 (en) * | 2000-01-31 | 2001-08-09 | Pfizer Products Inc. | Pyrimidine carboxamides useful as inhibitors of pde4 isozymes |
| AU2001261031A1 (en) * | 2000-04-17 | 2001-10-30 | Childrens Hospital Research Foundation | Inhibition of bone tumor formation using antisense cdna therapy |
| KR100608405B1 (ko) * | 2000-05-02 | 2006-08-02 | 에프. 호프만-라 로슈 아게 | 신규한 감마 선택적인 레티노이드 |
| US6740333B2 (en) * | 2000-07-07 | 2004-05-25 | Anestic Aps | Suppository and composition comprising at least one polyethylene glycol |
| US7485320B2 (en) * | 2000-09-25 | 2009-02-03 | Industrial Technology Research Institute | Liposome for incorporating large amounts of hydrophobic substances |
| US6660034B1 (en) * | 2001-04-30 | 2003-12-09 | Advanced Cardiovascular Systems, Inc. | Stent for increasing blood flow to ischemic tissues and a method of using the same |
| SE0101702D0 (sv) * | 2001-05-15 | 2001-05-15 | Ardenia Investments Ltd | Novel potentiating compounds |
| EP1401506A4 (en) * | 2001-05-31 | 2005-02-16 | Miravant Pharm Inc | METAL TETRAPYRROLIC PHOTOSENSITIZATION AGENTS FOR PHOTODYNAMIC THERAPY |
| ES2284959T3 (es) * | 2001-10-30 | 2007-11-16 | Nektar Therapeutics Al, Corporation | Conjugados polimericos solubles en agua de acido retinoico. |
| US6524606B1 (en) * | 2001-11-16 | 2003-02-25 | Ap Pharma, Inc. | Bioerodible polyorthoesters containing amine groups |
| US20040122080A1 (en) * | 2002-03-22 | 2004-06-24 | Vivat-Hannah Valerie S | Synergist combinations of retinoid receptor ligands and selected cytotoxic agents for treatment of cancer |
| US6869591B2 (en) * | 2002-03-26 | 2005-03-22 | Barnes-Jewish Hospital | Paramagnetic particles that provide improved relaxivity |
| WO2004009538A1 (en) * | 2002-07-23 | 2004-01-29 | Ardenia Investments Ltd. | Retinol derivatives, their use in the treatment of cancer and for potentiating the efficacy of other cytotoxic agents |
| US7148211B2 (en) * | 2002-09-18 | 2006-12-12 | Genzyme Corporation | Formulation for lipophilic agents |
| WO2004050101A2 (en) * | 2002-11-29 | 2004-06-17 | Gpc Biotech Ag | Formulations useful against hepatitis c virus infections |
| US20040138154A1 (en) * | 2003-01-13 | 2004-07-15 | Lei Yu | Solid surface for biomolecule delivery and high-throughput assay |
| US8969543B2 (en) * | 2003-04-03 | 2015-03-03 | Bioneer Corporation | SiRNA-hydrophilic polymer conjugates for intracellular delivery of siRNA and method thereof |
| US7064127B2 (en) * | 2003-12-19 | 2006-06-20 | Mount Sinai School Of Medicine Of New York University | Treatment of hepatic fibrosis with imatinib mesylate |
| US7284401B2 (en) * | 2004-01-12 | 2007-10-23 | Boston Scientific Scimed, Inc. | Stent reducing system and device |
| US7304045B2 (en) * | 2004-10-05 | 2007-12-04 | Hsing-Wen Sung | Nanoparticles for targeting hepatoma cells |
| PT2730277T (pt) * | 2004-12-22 | 2020-04-21 | Nitto Denko Corp | Veículo de fármaco e kit de veículo de fármaco para a inibição da fibrose |
| EP2206736B1 (en) * | 2005-12-05 | 2012-02-08 | Nitto Denko Corporation | Polyglutamate-amino acid conjugates and methods |
| JP5342834B2 (ja) * | 2008-09-05 | 2013-11-13 | 日東電工株式会社 | 骨髄線維症処置剤 |
| US7700541B2 (en) * | 2006-04-06 | 2010-04-20 | Nitto Denko Corporation | Biodegradable cationic polymers |
| CA2698812A1 (en) * | 2007-09-14 | 2009-03-19 | Nitto Denko Corporation | Drug carriers |
-
2008
- 2008-09-12 CN CN2008801311871A patent/CN102159247A/zh active Pending
- 2008-09-12 EP EP08822306.0A patent/EP2323693B1/en not_active Not-in-force
- 2008-09-12 RU RU2011107076/15A patent/RU2505315C2/ru not_active IP Right Cessation
- 2008-09-12 KR KR1020147011804A patent/KR20140065017A/ko not_active Ceased
- 2008-09-12 US US12/210,125 patent/US20100028416A1/en not_active Abandoned
- 2008-09-12 TW TW097135220A patent/TW201004646A/zh unknown
- 2008-09-12 AU AU2008359989A patent/AU2008359989A1/en not_active Abandoned
- 2008-09-12 ES ES08822306.0T patent/ES2657214T3/es active Active
- 2008-09-12 JP JP2011521085A patent/JP2011529492A/ja active Pending
- 2008-09-12 CA CA2732412A patent/CA2732412C/en not_active Expired - Fee Related
- 2008-09-12 WO PCT/US2008/076295 patent/WO2010014117A1/en not_active Ceased
- 2008-09-12 KR KR1020117004847A patent/KR20110051214A/ko not_active Ceased
-
2013
- 2013-10-17 RU RU2013146387/15A patent/RU2013146387A/ru not_active Application Discontinuation
-
2014
- 2014-01-29 US US14/167,223 patent/US20140212474A1/en not_active Abandoned
- 2014-02-05 JP JP2014019952A patent/JP2014129364A/ja active Pending
-
2015
- 2015-11-24 JP JP2015228674A patent/JP2016104732A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2011529492A5 (enExample) | ||
| Curreri et al. | RNA therapeutics in the clinic | |
| CN1139385C (zh) | 用于脂化亲水分子的方法和组合物 | |
| Tierney et al. | The development of non-viral gene-activated matrices for bone regeneration using polyethyleneimine (PEI) and collagen-based scaffolds | |
| Uchida et al. | Design concepts of polyplex micelles for in vivo therapeutic delivery of plasmid DNA and messenger RNA | |
| Agarwal et al. | PDMAEMA based gene delivery materials | |
| EP3704262B1 (en) | Multiplexed analysis of materials for tissue delivery | |
| ES2826203T3 (es) | Suministro pulmonar de ARN mensajero | |
| ES2724853T3 (es) | Conjugados de oligonucleótidos | |
| ES2562499T3 (es) | Modulación de la expresión de HSP47 | |
| JP2006500917A5 (enExample) | ||
| EA028860B1 (ru) | Улучшенная липидная композиция | |
| CN103153347A (zh) | 用于寡核苷酸递送的新型低分子量阳离子脂质 | |
| Wang et al. | Dual‐targeting heparin‐based nanoparticles that re‐assemble in blood for glioma therapy through both anti‐proliferation and anti‐angiogenesis | |
| Dutta et al. | Charge‐conversion strategies for nucleic acid delivery | |
| WO2007089607A3 (en) | Rna silencing agents for use in therapy and nanotransporters for efficient delivery of same | |
| US20190382790A1 (en) | Perfluorocarbylated compounds for the non-viral transfer of nucleic acids | |
| WO2007069068A3 (en) | Cell penetrating peptide conjugates for delivering nucleic acids into cells | |
| Han et al. | Optimization of the activity and biodegradability of ionizable lipids for mRNA delivery via directed chemical evolution | |
| WO2006007712A8 (en) | Methods comprising polyethylene glycol-lipid conjugates for delivery of therapeutic agents | |
| CY1116482T1 (el) | Συνθεσεις και μεθοδοι για τη θεραπεια ογκων, ινωσης, και πνευμονικης κυψελιδικης πρωτεϊνωσης | |
| Liu et al. | Virus spike and membrane-lytic mimicking nanoparticles for high cell binding and superior endosomal escape | |
| CN116949050A (zh) | mRNA的功能化方法 | |
| CN103893124A (zh) | 基于协同组装的基因治疗药物递送系统 | |
| Akhter et al. | A liposomal delivery system that targets liver endothelial cells based on a new peptide motif present in the ApoB-100 sequence |